BDBM317605 US9624199, 15::[(3R)-3-Methyl-1,4′-bipiperidin-1′-yl][6-(3-methylpiperidin-1-yl)pyridin-3-yl]methanone
SMILES: C[C@@H]1CCCN(C1)C1CCN(CC1)C(=O)c1ccc(nc1)N1CCCC(C)C1
InChI Key: InChIKey=CMIMSJDBHHVNGT-MRTLOADZSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Alpha-1A adrenergic receptor (Homo sapiens (Human)) | BDBM317605 (US9624199, 15 | [(3R)-3-Methyl-1,4′-bipiperi...) | Reactome pathway KEGG UniProtKB/SwissProt DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | n/a | n/a | 27 | n/a | n/a | n/a | n/a | n/a | n/a |
Bayer Pharma Aktiengesellschaft US Patent | Assay Description To prepare cell membranes with human α1- and α2-adrenergic receptors, CHO cells stably overexpressing α1- and α2-adrenergic recep... | US Patent US9624199 (2017) BindingDB Entry DOI: 10.7270/Q2ZG6VB7 | |||||||||||
More data for this Ligand-Target Pair |